Bobak R. Azamian - 06 Jan 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
06 Jan 2023
Transactions value $
-$6,165
Form type
4
Filing time
24 Jan 2023, 17:13:23 UTC
Previous filing
22 Dec 2022
Next filing
11 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale -$6.17K -411 -0.04% $15.00 1.13M 06 Jan 2023 By the Bobak Azamian Living Trust established April 16, 2018 F1, F2, F3, F4
holding TARS Common Stock 1.75K 06 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2022.
F2 The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $15.00 to $15.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This is an inadvertent late filing due to an administrative error. As a result of this administrative error, the shares sold on January 6, 2023 were erroneously included in the Table I, Column 5 totals of the Form 4s filed by the Reporting Person on January 11, 2023, January 13, 2023 and January 20, 2023.
F4 The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.